NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Clinical Trials Week


Susan Hasty, Publisher
Table of Contents . . . March 2nd, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Clinical Trials Week | Other Publications

Alkermes, Inc. - Alkermes Announces Initiation of Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD

Anacor Pharmaceuticals - Anacor Announces Positive Results from Phase 2 Psoriasis Trial

HepaLife Technologies - HepaLife™ Plans for Phase III Clinical Trial for HepaMate™ Bioartificial Liver System

Hepatitis C Virus - Romark Announces Presentation of New Data for Controlled Release Nitazoxanide in Chronic Hepatitis C

Reata Pharmaceuticals, Inc. - Reata’s Antioxidant Inflammation Modulator Shows Promise for COPD in Study Published in Proceedings of the National Academy of Sciences

Actinic Keratosis - Studies from G. Siller and colleagues yield new information about actinic keratosis

B-Cell Lymphoma - New findings from K. Tobinai and co-researchers in the area of B-cell lymphoma described

Breast Cancer - Investigators at Duke University zero in on breast cancer

Breast Cancer - New findings from E. Campora and co-authors in the area of breast cancer published

Breast Cancer - Research conducted at R.L. Jones and co-authors has provided new information about breast cancer

Breast Cancer - Research data from A. Hirano and colleagues update understanding of breast cancer

Cancer - Recent studies by S. Sharma and co-authors add new data to cancer findings

Cervical Cancer - Study findings on cervical cancer are outlined in reports from University of Oklahoma

Chronic Lymphocytic Leukemia - Research conducted at Ohio State University has updated our knowledge about chronic lymphocytic leukemia

Clinical Trial Research - New clinical trial research study results reported from Duke University, Medical Department

Esophageal Cancer - New findings reported from University of Toronto describe advances in esophageal cancer

Gastric Cancer - Reports on gastric cancer findings from Seoul National University, Medical Department provide new insights

Graft-Versus-Host Disease - Research in the area of graft-versus-host disease reported from Nagoya University, Medical Department

Hepatitis C Virus - Reports from University of Palermo advance knowledge in hepatitis C virus

Herpesvirus - Scientists at University of Alabama publish new data on herpesvirus

HIV/AIDS - Research on HIV/AIDS discussed by scientists at GlaxoSmithKline

Lung Cancer - Research from T. Neuhaus and co-authors provides new data about lung cancer

Lymphoma - Studies from Ruhr University provide new data on lymphoma

Mass Spectrometry - Yokohama City University, Medical Department publishes research in mass spectrometry

Melanoma - New data from J. Lutzky et al illuminate research in melanoma

Ovarian Cancer - New ovarian cancer study findings reported from P. Braly and co-authors

Ovarian Cancer - Researchers at National Taiwan University, Medical Department publish new data on ovarian cancer

Pharmacokinetics - Research conducted at R.Z. Yu and co-authors has provided new information about pharmacokinetics

Rectal Cancer - Studies from F. Bertolini et al in the area of rectal cancer described

Thrombocytopenic Purpura - Researchers' work from University of Oklahoma focuses on thrombocytopenic purpura

B-Cell Lymphoma Therapy - Findings from S. Pulini and co-authors broaden understanding of B-cell lymphoma therapy

Cancer - Investigators at National Cancer Institute target cancer

Dialysis - Investigators at Showa University, Department of Medicine zero in on dialysis

Gastric Cancer Therapy - Reports outline gastric cancer therapy research from Hallym University, Department of Internal Medicine

Hepatitis B Virus Therapy - Findings from Okayama University in hepatitis B virus therapy reported

Iron Overload Prevention - Investigators at University of Heidelberg publish new data on iron overload prevention

Ovarian Cancer Therapy - New data from I. Ray-Coquard et al illuminate research in ovarian cancer therapy

Abbott; Enanta Pharmaceuticals - Abbott and Enanta Initiate Phase 1 Clinical Trial on ABT-450 HCV Protease Inhibitor

Access Pharmaceuticals, Inc. - Access Licenses ProLindac and MuGard to JCOM Ltd, an Affiliate of DONG-A Pharmaceuticals in Korea

Acucela Inc. - Acucela Founder to Speak at Ophthalmology Conference

Applied Pharma Research - APR Acquires a New Drug Delivery Nanotechnology Platform Providing Innovative Treatment Solutions for Critical Diseases

Bird Flu - Novavax Presents Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program at World Health Organization Conference

Breast Cancer - CuraGen's Board of Directors to Evaluate Strategic Initiatives

Clinical Trial Research - Arena Pharmaceuticals Announces Initiation by Merck of Phase 2 Clinical Trial of Niacin Receptor Agonist

Clostridium - Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile

Cubist Pharmaceuticals, Inc. - Phase 1 Trial Begins for Investigational New Drug for MDR Gram-negative Infections

Duke University Medical Center - Questions of ethics and quality cloud globalization of clinical trials

Endocyte Inc. - Endocyte Begins Phase II Clinical Trial of EC145 for Treatment of Women with Ovarian Cancer

Enzon Pharmaceuticals, Inc. - Enzon Reports 2008 Results

Genta Incorporated - Genta Incorporated Announces Fourth Quarter and Year End 2008 Financial Results and Corporate Highlights

GPC Biotech AG - GPC Biotech and Agennix Announce Proposed Merger

Incyte Corporation - Incyte Reports Fourth Quarter and Year-End 2008 Financial Results; Announces 2009 Financial Guidance

KYTHERA BIOPHARMACEUTICALS, Inc. - KYTHERA BIOPHARMACEUTICALS Secures Additional $10M

Lux Biosciences, Inc. - Lux Biosciences Initiates Phase 1 Study of LX214, a Development Candidate for Dry Eye Syndrome

Parkinson Disease - Groundbreaking Paper Publishes Long Term Results of a Successful Phase I Clinical Trial Using Autologous Neural Stem Cells to Treat Parkinson's Disease

Poniard Pharmaceuticals, Inc. - Poniard Pharmaceuticals Announces Appointment of Greg Weaver as Chief Financial Officer

Seattle Genetics, Inc. - Seattle Genetics Initiates Pivotal Trial of SGN-35 for Hodgkin Lymphoma

Solid Cancer - Dosing Begins in Phase 1 Clinical Study Evaluating NKTR-105 in Cancer Patients With Refractory Solid Tumors

StemCells, Inc. - StemCells, Inc. Comments on PLoS Medicine Article Concerning Cell Transplants in Russia

Sucampo Pharmaceuticals, Inc. - Sucampo Licenses Lubiprostone in Japan to Abbott

Type 2 Diabetes - Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes

Wolfe Laboratories, Inc. - Wolfe Laboratories Hosts 2009 Biopharma Conference and United Way Fundraiser

Wyeth Pharmaceuticals - CONBRIZA Receives Positive CHMP Opinion for the Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture



Return to Top of Page

-----------------------
PR Login